Principal Financial Group Inc. Acquires 34393 Shares of Cimarex Energy Co (XEC)

Marco Green
November 15, 2017

Magnetar Financial LLC now owns 10,758 shares of the oil and gas producer's stock valued at $1,223,000 after purchasing an additional 4,064 shares in the last quarter. Alexion Pharmaceuticals Inc now has $24.57 billion valuation. (NYSE:XEC)'s stock was -10.32%. About 2.39 million shares traded or 14.90% up from the average. It is down 1.88% since November 13, 2016 and is uptrending.

First Quadrant L P CA trimmed its holdings in Cimarex Energy Co (NYSE:XEC) by 81.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. TEAGUE L PAUL also sold $124,560 worth of Cimarex Energy Co (NYSE:XEC) on Monday, May 15. The stock has "Neutral" rating by Goldman Sachs on Tuesday, May 3. The stock had a trading volume of 465,500 shares, compared to its average volume of 827,732. Oakbrook Investments Llc who had been investing in Cimarex Energy Co. for a number of months, seems to be less bullish one the $11.91 billion market cap company. It has underperformed by 14.82% the S&P500. KeyCorp restated a "buy" rating and set a $130.00 price objective on shares of Cimarex Energy in a research report on Friday, October 20th. Therefore 64% are positive. The firm earned "Buy" rating on Wednesday, November 8 by KeyBanc Capital Markets. Citigroup Inc. cut their price objective on shares of Cimarex Energy from $150.00 to $135.00 and set a "buy" rating on the stock in a research note on Thursday, July 13th. The stock has a consensus rating of "Buy" and a consensus price target of $132.82.

Cimarex Energy (NYSE:XEC) last issued its quarterly earnings data on Tuesday, November 7th. RBC Capital Markets maintained the stock with "Hold" rating in Wednesday, June 28 report. As per Tuesday, July 4, the company rating was maintained by Jefferies. Allstate invested 0.04% in Cimarex Energy Co (NYSE:XEC). Company insiders own 1.70% of the company's stock. It also increased its holding in Merck & Co. Inc. Propetro Hldg Corp was reduced too. Its up 0.80, from 1.15 in 2017Q1.

Other large investors have also recently bought and sold shares of the company. Institutions are now holders of 94.30% of the shares. New Mexico Educational Retirement Board reported 0.04% of its portfolio in Cimarex Energy Co (NYSE:XEC). Grace & White stated it has 10,968 shares.

Cimarex Energy Co. (NYSE:XEC)'s RSI (Relative Strength Index) is 50.61. Voya Investment Mgmt Ltd Limited Liability Company holds 0.01% or 60,662 shares. Following the sale, the director now owns 41,146 shares in the company, valued at $5,144,484.38. Sumitomo Mitsui Tru has invested 0.04% of its portfolio in Cimarex Energy Co (NYSE:XEC). American Century Incorporated has 0.07% invested in Cimarex Energy Co (NYSE:XEC).

The latest insider trades for Cimarex Energy Co. After $0.17 actual EPS reported by Valley National Bancorp for the previous quarter, Wall Street now forecasts 0.00% EPS growth. Airain reported 46,821 shares. Macquarie Gp Ltd invested in 2,200 shares. Tru Co Of Toledo Na Oh owns 2,885 shares or 0.07% of their USA portfolio. Nomura Hldgs accumulated 21,385 shares or 0% of the stock.

There is plenty of insight we can gain about how a company is doing financially by looking at the selling and buying activity of insiders, which are directors and senior officers of a business - or any entity or person that holds more than ten percent of that company's voting shares.

In other Cimarex Energy news, COO Joseph R. Albi sold 2,000 shares of the stock in a transaction that occurred on Wednesday, September 13th.

Among 28 analysts covering Alexion Pharmaceuticals Inc. Ten research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. Therefore 79% are positive. Turquoise Hill Resources had 12 analyst reports since September 29, 2015 according to SRatingsIntel. The firm has "Buy" rating by BMO Capital Markets given on Tuesday, June 13. Brean Capital maintained the shares of SSB in report on Monday, October 30 with "Hold" rating. The company was upgraded on Thursday, April 21 by Credit Suisse. The rating was initiated by RBC Capital Markets with "Sector Perform" on Monday, July 18. Stifel Nicolaus maintained Alexion Pharmaceuticals, Inc. UBS upgraded the stock to "Buy" rating in Friday, October 21 report. The stock has "Hold" rating by Canaccord Genuity on Wednesday, August 17. The stock has "Hold" rating by Standpoint Research on Wednesday, August 26. $97,511 worth of Alexion Pharmaceuticals, Inc. HANTSON LUDWIG had bought 10,000 shares worth $1.17 million. Winch Advisory Services Lc reported 1,557 shares. It fall, as 40 investors sold XEC shares while 146 reduced holdings. 16 funds opened positions while 56 raised stakes. South Dakota Invest Council reported 0.24% stake. Glg Prtn Lp owns 12,234 shares. The institutional investor held 759,980 shares of the industrial specialties company at the end of 2017Q2, valued at $15.85 million, up from 722,655 at the end of the previous reported quarter. Price T Rowe Associate Md holds 0.5% or 22.82 million shares in its portfolio. Amalgamated Comml Bank invested in 25,568 shares. Federated Pa holds 2,120 shares or 0% of its portfolio. (NASDAQ:ALXN) for 668,143 shares.

When the subject is institutional holdings, checking out a company's current active positions can help us get a glimpse of how institutional investors view the value of the company's shares. (NASDAQ:ALXN) for 6 shares.

Receive News & Ratings for Cimarex Energy Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cimarex Energy Co and related companies with MarketBeat.com's FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER